Use of Shigella Invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo

Details for Australian Patent Application No. 2004293031 (hide)

Owner The Government of the United States, as represented by the Secretary of the Army

Inventors Kaminski, Robert W.; Oaks, Edwin V.

Agent Griffith Hack

Pub. Number AU-B-2004293031

PCT Pub. Number WO2005/051421

Priority 60/524,639 25.11.03 US

Filing date 23 November 2004

Wipo publication date 9 June 2005

Acceptance publication date 31 March 2011

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/051421 Priority application(s): WO2005/051421

24 May 2007 Assignment before Grant

  Kaminski, Robert W.; The Government of the United States, as represented by the Secretary of the Army The application has been assigned to The Government of the United States, as represented by the Secretary of the Army 2005

31 March 2011 Application Accepted

  Published as AU-B-2004293031

28 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004293034-EphA2 agonistic monoclonal antibodies and methods of use thereof

2004293030-Electrical devices and anti-scarring agents